Navigation Links
Silicone Strip (20 Style)

ProductsSilicone Strip (20 Style)
Company Bausch & Lomb Storz
Item Silicone Strip (20 Style)
Features 
Description Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Narrow scleral bed. Overall length: 100 mm, 3.9 inches.
Info Bausch & Lomb Storz
Customer Service: (585) 338-6000

Related medicine products :

1. Non-sterile Silicone Tubing
2. Silicone Strip (31 Style)
3. Silicone Tire (78G Style)
4. Silicone Strip (32 Style)
5. Silicone Hemisphere (77G Style)
6. Silicone Boat (60 Style)
7. Silicone Strip (220 Style)
8. Silicone Strip (219 Style)
9. Silicone Strip (225 Style)
10. Silicone Tire (287 Style)
11. Silicone Tire (277 Style)
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
Medicine Products:
(Date:12/3/2008)..., Dec. 3 Medical transc...e United States$6.6 million to resolve allegations...eral government clients, the Justice Department an...d medical transcription services to several federa...Veterans Affairs (VA), the Department of Defense (...
(Date:12/3/2008)... Hyperdrug are offering free shippi... (PRWEB) November 2, 2009 -- For the remainder...luding flea treatment Frontline , to UK mainland ...ll be free to customers entering the special vouch... , , ,Hyperdrug director Ben Watson says "Hyp...
(Date:12/3/2008)...l researchers at UCLA have proven definitively tha... embryonic development by endothelial cells, the c...While the anatomic location in the embryo where bl... the cell type from which they spring was less und..., 2008 issue of the journal Cell Stem Cell , puts...
(Date:12/3/2008)...Y HILLS, Dec. 3 As the classic say..." However, it seems American women would rather,...commissioned by ZO Skin,Health and reveals that o... a,facial care system that would make them look 1... that would make them lose 10 pounds. , The...
Breaking Medicine News(10 mins):Health News:New Jersey-Based MedQuist Pays U.S. $6.6 Million to Resolve False Claims Act Allegations 2Health News:Beating the Credit Crunch with Hyperdrug.co.uk 2Health News:UCLA scientists prove endothelial cells give rise to blood stem cells 2Health News:UCLA scientists prove endothelial cells give rise to blood stem cells 3Health News:What Will Women Give Up for Skin Health? 2
...IV leads to a complex disorder that combines a chr...ssive decrease in the number of T-cells, which are...ells falls below // a certain level, the weakened ...ctions, and the symptoms of AIDS develop. New rese...
...stimates show white children under age 2 who were ...er risk of behavior problems that // required a pa...d to children who were not spanked. However, the l...ems in black and Hispanic children was not signifi...
...eanut allergy is the third most common food allerg...lergy in older children, adolescents and adults.//...e not allergic to peanuts. Participants washed wit...and an antibacterial hand sanitizer after applying...
...ough is the fifth most common complaint seen in th...visits annually. Chronic cough is considered a dis...ratory tract and upper // part of the digestive tr...The common treatments are successful for a great m...
Other Medicine News:
(Date:12/3/2008)...RNewswire-FirstCall/ -- Vical Incorporated,(Nasda...letter of intent with EIP,Eczacibasi Ilac Pazarla...ny,s,Allovectin-7(R) immunotherapeutic product ca...thern Cyprus. EIP has agreed to obtain the necessa...pay Vical upfront and milestone payments,plus a s...
(Date:12/2/2008)...c. 2 TorreyPines Therapeutics, Inc...ts from a 26 patient Phase II trial evaluating thr...or dry mouth, in patients with Sjogren,s syndrome....ly significant increase in salivary flow productio...5 mg, and 20 mg. These doses were safe and well to...
(Date:12/1/2008)... 1 Vanda Pharmaceuticals...e Lancet , one of the world,s leading medical jour...adian regulator, experimental compound tasimelteon...) is entitled "Melatonin agonist tasimelteon (VEC-...: two randomised controlled multicentre trials." R...
(Date:12/1/2008)... the Prox1 gene is a two-way switch that, if turne...programmed so that they lose their identity and be...MEMPHIS, Tenn., Dec. 1 ...al have discovered that a certain differentiated c...t requires the constant expression of a gene calle...
Breaking Medicine Technology:Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008 8650 1Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008 8650 2Nycomeds Daxas 28R 29 Shows Encouraging Preliminary Results in Phase III COPD Studies 8648 1Nycomeds Daxas 28R 29 Shows Encouraging Preliminary Results in Phase III COPD Studies 8648 2Nycomeds Daxas 28R 29 Shows Encouraging Preliminary Results in Phase III COPD Studies 8648 3InterMune to Release Third Quarter 2008 Financial Results on November 6 8646 1InterMune to Release Third Quarter 2008 Financial Results on November 6 8646 2FTC Extends Final Red Flag Compliance Deadline for Creditors 27863 1FTC Extends Final Red Flag Compliance Deadline for Creditors 27863 2
...k today announced clinical,results from the first ...e-daily human GLP-1 analogue. The 26-week study is...on in Diabetes) programme,and included 581 patient...two of the most widely used oral antidiabetic drug... patients in the,study continued the two oral drug...
...E)--Jun 21, 2007 - Nymox,Pharmaceutical Corporatio...ults from the Company,s recently completed studies... will be presented at,a series of upcoming U.S. ur...h Central American Urological Association Meeting ...entations will be,given by leading clinical resear...
Other Medicine Technology:Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 2Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 3Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 4Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2